Actively Recruiting
Evaluation of Different Thromboplastin Reagents for Prothrombin Time and Factor Assays in Patients with Extrinsic Pathway Factor Deficiency or Liver Disease
Led by University Hospital, Strasbourg, France · Updated on 2026-08-19
20
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the sensitivity of various thromboplastin reagents to prothrombin time and factor II, V, VII, and X assays in two groups of patients those with isolated extrinsic pathway factor deficiencies either acquired or congenital and those with liver damage causing coagulopathy proportional to the severity of liver impairment. This diagnostic study aims to improve understanding of how prothrombin time screening tests perform based on the origin of the thromboplastin reagent used, assisting laboratories in choosing the most appropriate reagent. The study compares prothrombin time results using different thromboplastin reagents derived from animal sources, human synthetic recombinant, and human placental extraction. Plasma samples are collected, frozen at -80C within three hours, and later thawed and analyzed to assess sensitivity through regression and Bland-Altman methods. The study evaluates factor assays and the sensitivity of prothrombin time based on activity rates for each reagent across the two patient groups. Participants provide plasma samples collected during routine testing, which are anonymized before analysis. Researchers measure prothrombin time and factor activities using various reagents, comparing their sensitivity and performance. The primary outcome is the comparison of sensitivity among these reagents. The study is non-randomized, with no masking, and is expected to complete by December 2026. Participants are not exposed to direct treatment, and their samples support this diagnostic evaluation.
CONDITIONS
Brief Title
Comparative Evaluation of the Performance of Different Thromboplastin Reagents on Prothrombin Time in Situations of Isolated Extrinsic Pathway Factor Deficiency or Liver Damage
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here